Esirock 5 Tablet contains Escitalopram Oxalate 5 mg, a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD). Escitalopram functions by increasing the levels of serotonin, a neurotransmitter, in the brain, thereby helping to improve mood, reduce anxiety, and restore emotional balance. This medication is indicated for adults and adolescents aged 12 years and above and should be used under medical supervision. Esirock 5 Tablet is typically administered once daily, with or without food, and dosage adjustments may be necessary based on clinical response and tolerability. Common side effects may include nausea, headache, dry mouth, insomnia, and dizziness, which often diminish with continued use. Patients should be monitored for any signs of worsening depression, suicidal ideation, or unusual behavioral changes, particularly during the initial treatment period or dosage modifications. Caution is advised when used concomitantly with other serotonergic agents due to the risk of serotonin syndrome. Esirock 5 Tablet is contraindicated in individuals with known hypersensitivity to escitalopram or any of its components. It is essential to inform the healthcare provider of any existing medical conditions or concomitant medications prior to initiating therapy.